Melly LIN

Melly Lin has joined Roche PTR policy group as regulatory manager for China since 2011. She is responsibility for the oversight and development of all technical regulatory policy and influencing efforts in China, including the establishment of strong and effective relationships with the Chinese regulatory agencies, as well the local pharmaceutical industry associations. In addition, Melly provides direct support to the Technical Regulatory Leads in defining the regulatory strategy for development and marketed projects in China.

Melly became member of DIA China Advisory Committee since 2015 and have organized many biological and CMC related sessions on China DIA in the last 5 years.